Polymyxin B-induced acute kidney injury in a burn patient: a case report and pharmaceutical care
Frontiers in Medicine · 07.05.2026 · 13
DOI: 10.3389/fmed.2026.1817208 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Medicine, online erschienen am 07.05.2026. Verfasst von Shanshan Ding. Beteiligte Einrichtung: Department of Clinical Pharmacy, Jinan Central Hospital, Jinan, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Polymyxin B is increasingly used against multidrug-resistant Gram-negative bacteria but carries a risk of acute kidney injury (AKI). Burn patients are particularly vulnerable. Case summary A 44-year-old male with 66% TBSA burns and sepsis received polymyxin B (50 mg q12h, then escalated to 100 mg q12h). Serum creatinine rose from 59 to 163 μmol/L within 3 days, meeting KDIGO AKI criteria. No other nephrotoxic agents were used. The Naranjo score was 5, indicating probable polymyxin B-induced AKI. After dose reduction to 50 mg q12h, renal function improved without discontinuing therapy.
Conclusion
In burn patients, early renal function monitoring (within 3 days) and dose adjustment based on infection response and renal biomarkers are critical. Therapeutic drug monitoring is recommended when available.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Jinan Central Hospital, Jinan, China.
Zitieren
APA
Ding, S. (2026). Polymyxin B-induced acute kidney injury in a burn patient: a case report and pharmaceutical care. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1817208
Vancouver
Ding S. Polymyxin B-induced acute kidney injury in a burn patient: a case report and pharmaceutical care. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1817208
BibTeX
@article{Ding2026,
author = {Ding, Shanshan},
title = {Polymyxin B-induced acute kidney injury in a burn patient: a case report and pharmaceutical care},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1817208}
}
EUVIMED